Selected angle: source

One-sentence thesis

The cited A/B receipts support a specific working claim: Telomeres length of T helper, T cytotoxic, natural killer and B cells increased significantly by over 20% following HBOT; There was a significant decrease in the number of senescent T helpers by -37.30%±33.04 post-HBOT. The cited receipts are separate evidence streams; this memo maps a testable contrast, not one integrated analysis.

Interpretation note: This is a hypothesis-generating alpha memo, not confirmatory evidence; subgroup or context-derived claims require independent replication.

Why this is surprising

HBOT's capacity to reduce senescent cells and lengthen telomeres presents a mechanistic bridge between its efficacy in chronic wounds and neurological conditions, yet the clinical translation of these cellular changes remains unverified.

Known / obvious (do not republish): HBOT improves healing of diabetic foot ulcers; HBOT reduces major amputations in diabetic foot ulcers; HBOT improves cognitive function in vascular dementia

Real tension: HBOT reduces major amputations but not minor amputations in diabetic foot ulcers (fact 18 vs 3)

Evidence receipts

• fact_id=188537 (A_core) — Telomeres length of T helper, T cytotoxic, natural killer and B cells increased significantly by over 20% following HBOT. doi=10.18632/aging.202188
• fact_id=188541 (A_core) — There was a significant decrease in the number of senescent T helpers by -37.30%±33.04 post-HBOT. doi=10.18632/aging.202188
• fact_id=188542 (A_core) — T-cytotoxic senescent cell percentages decreased significantly by -10.96%±12.59 (p=0.0004) post-HBOT. doi=10.18632/aging.202188
• fact_id=144916 (A_core) — HBOT was significantly effective in complete healing of diabetic foot ulcer (OR = 0.29; 95% CI 0.14-0.61; I2 = 62%) doi=10.1038/s41598-021-81886-1
• fact_id=144917 (A_core) — HBOT effective in reduction of major amputation (RR = 0.60; 95% CI 0.39-0.92; I2 = 24%) doi=10.1038/s41598-021-81886-1
• fact_id=187988 (A_core) — HBOT strikingly improved the Mini-Mental State Examination (MMSE) (MD = 4.00; 95% CI = 3.28-4.73; P < 0.00001) doi=10.3389/fnagi.2019.00086
• fact_id=187991 (A_core) — HBOT increased the total efficacy rate (TEF) (OR = 4.84, 95% CI = 3.19-7.33, P < 0.00001) doi=10.3389/fnagi.2019.00086
• fact_id=190396 (A_core) — a higher incidence of complete healing was noted with group B (20%) than with group A (4.5%) and group C (3.8%). doi=10.1111/wrr.12853
• fact_id=187957 (A_core) — Two studies found no difference in major amputation rate, whereas one large retrospective study found 2% more major amputations in the hyperbaric oxygen group. doi=10.1111/wrr.12776

What this changes

Treat this as a focused working signal, not a broad topic claim. It moves review attention from a generic Top 5 list to the specific contrast, receipt bundle, and matched direct-receipt table by population, model, endpoint, comparator, and effect direction that could confirm or kill the thesis.

Limitations

• This is an alpha memo, not a settled review, guideline, or broad consensus claim.
• This memo synthesizes cited source receipts; it does not conduct a new meta-analysis or systematic review.
• Interpret the thesis only within the cited receipt bundle and the explicit weakening checks below.
• Independent receipts fail to reproduce the claimed contrast.
• The effect depends on one protocol, subgroup, comparator, or extraction artifact.

What would weaken this

• Independent receipts fail to reproduce the claimed contrast.
• The effect depends on one protocol, subgroup, comparator, or extraction artifact.

Strongest counter-evidence

• fact_id=187957 (A_core) — Two studies found no difference in major amputation rate, whereas one large retrospective study found 2% more major amputations in the hyperbaric oxygen group. Source: Hyperbaric oxygen therapy for nonischemic diabetic ulcers: A systematic review

Next extraction

• Extract independent A_core/B_context receipts that test the lead contrast directly.
• Audit whether each direct receipt remains comparable on population, endpoint, comparator, and measurement method.